Catalent to Add Early Development & Spray Dry Capabilities
Catalent has announced that it has signed an agreement to acquire West Coast-based drug development and clinical manufacturing specialist, Pharmatek Laboratories. The acquisition will add extensive additional capacity to Catalent's existing early-phase drug development capabilities from discovery to clinic, bring spray dry technology into Catalent’s portfolio of drug formulation and delivery technologies, and expand Catalent’s Optiform® Solution Suite for bioavailability enhancement.
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.
Explore The Range of Delivery Options for Your Molecule
This web tool enables drug development professionals to solve one of the most challenging aspects in drug development, determining the optimal finished dose suited to your specific product requirements, target indication and molecule properties.
Discover solutions to improve the value of your treatments at every clinical stage.
Easily browse 300+ proven consumer product formulas to find the technology you need.
Learn more about our tailored solutions for Consumer Health, Animal Health & Biologics.